Healthcare provider profile · identity verified

Ingrid Passier, FNP

Nurse Practitioner · CENTRAL POINT, OR · NPI 1326783184

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	409	49
Sertraline Hcl	Sertraline Hcl	350	47
Atorvastatin Calcium	Atorvastatin Calcium	346	50
Gabapentin	Gabapentin	312	38
Omeprazole	Omeprazole	285	47
Furosemide	Furosemide	279	48
Potassium Chloride	Potassium Chloride	268	44
Amlodipine Besylate	Amlodipine Besylate	266	41
Quetiapine Fumarate	Quetiapine Fumarate	257	33
Trazodone Hcl	Trazodone Hcl	256	46
Metoprolol Succinate	Metoprolol Succinate	255	38
Losartan Potassium	Losartan Potassium	248	37
Lisinopril	Lisinopril	245	43
Citalopram Hbr	Citalopram Hydrobromide	219	34
Tamsulosin Hcl	Tamsulosin Hcl	219	32
Donepezil Hcl	Donepezil Hcl	206	35
Buspirone Hcl	Buspirone Hcl	185	25
Olanzapine	Olanzapine	174	33
Tramadol Hcl	Tramadol Hcl	169	35
Eliquis	Apixaban	161	21
Risperidone	Risperidone	160	16
Mirtazapine	Mirtazapine	148	25
Divalproex Sodium	Divalproex Sodium	140	22
Metformin Hcl	Metformin Hcl	138	20
Rosuvastatin Calcium	Rosuvastatin Calcium	125	22
Pantoprazole Sodium	Pantoprazole Sodium	124	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	119	23
Escitalopram Oxalate	Escitalopram Oxalate	111	15
Metoprolol Tartrate	Metoprolol Tartrate	109	17
Triamcinolone Acetonide	Triamcinolone Acetonide	104	56
Fluticasone Propionate	Fluticasone Propionate	103	30
Lorazepam	Lorazepam	103	36
Allopurinol	Allopurinol	98	13
Diclofenac Sodium	Diclofenac Sodium	95	34
Jardiance	Empagliflozin	95	12
Pregabalin	Pregabalin	92	17
Baclofen	Baclofen	83	11
Cephalexin	Cephalexin	83	57
Meloxicam	Meloxicam	82	11
Chlorthalidone	Chlorthalidone	80	11
Carvedilol	Carvedilol	78	13
Clopidogrel	Clopidogrel Bisulfate	78	13
Nystatin	Nystatin	77	36
Doxepin Hcl	Doxepin Hcl	75	15
Bupropion Hcl Sr	Bupropion Hcl	73	suppressed
Torsemide	Torsemide	71	15
Myrbetriq	Mirabegron	69	11
Xarelto	Rivaroxaban	69	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	66	53
Ketoconazole	Ketoconazole	66	20
Clonazepam	Clonazepam	65	suppressed
Nyamyc	Nystatin	65	33
Aripiprazole	Aripiprazole	62	suppressed
Alendronate Sodium	Alendronate Sodium	60	11
Simvastatin	Simvastatin	60	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	60	suppressed
Bupropion Xl	Bupropion Hcl	59	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	58	suppressed
Famotidine	Famotidine	55	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	55	suppressed
Ropinirole Hcl	Ropinirole Hcl	54	suppressed
Clotrimazole	Clotrimazole	53	20
Hydralazine Hcl	Hydralazine Hcl	53	12
Duloxetine Hcl	Duloxetine Hcl	52	suppressed
Finasteride	Finasteride	52	suppressed
Methenamine Hippurate	Methenamine Hippurate	52	suppressed
Estradiol	Estradiol	49	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	47	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	47	suppressed
Latanoprost	Latanoprost	46	suppressed
Levetiracetam	Levetiracetam	44	suppressed
Irbesartan	Irbesartan	43	suppressed
Metformin Hcl Er	Metformin Hcl	43	suppressed
Nifedipine Er	Nifedipine	43	suppressed
Ipratropium Bromide	Ipratropium Bromide	42	14
Prednisone	Prednisone	42	20
Oxycodone Hcl	Oxycodone Hcl	41	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Rivastigmine	Rivastigmine Tartrate	38	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	38	suppressed
Arnuity Ellipta	Fluticasone Furoate	37	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	36	suppressed
Trospium Chloride	Trospium Chloride	35	suppressed
Olanzapine Odt	Olanzapine	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Memantine Hcl	Memantine Hcl	32	suppressed
Montelukast Sodium	Montelukast Sodium	32	suppressed
Nystop	Nystatin	32	19
Lovastatin	Lovastatin	30	suppressed
Carbidopa-Levodopa-Entacapone	Carbidopa/Levodopa/Entacapone	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	24
Spironolactone	Spironolactone	27	suppressed
Alprazolam	Alprazolam	26	suppressed
Ibuprofen	Ibuprofen	26	suppressed
Methadone Hcl	Methadone Hcl	26	suppressed
Morphine Sulfate	Morphine Sulfate	26	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	25	suppressed
Indapamide	Indapamide	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	19
Primidone	Primidone	24	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Midodrine Hcl	Midodrine Hcl	22	suppressed
Oxcarbazepine	Oxcarbazepine	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	11
Doxycycline Hyclate	Doxycycline Hyclate	21	15
Digoxin	Digoxin	20	suppressed
Methimazole	Methimazole	20	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	19	suppressed
Topiramate	Topiramate	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Mupirocin	Mupirocin	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Zonisamide	Zonisamide	18	suppressed
Buprenorphine	Buprenorphine	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	12
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Glatiramer Acetate	Glatiramer Acetate	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Bromocriptine Mesylate	Bromocriptine Mesylate	13	suppressed
Calcitriol	Calcitriol	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Lactulose	Lactulose	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Naproxen	Naproxen	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Niacin Er	Niacin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error